Uncoupling between CD1d upregulation induced by retinoic acid and conduritol-B-epoxide and iNKT cell responsiveness

Immunobiology

Volumn 215, Issue 6, 2010, Pages 505-513

  Balreira, Andrea ^a,b   Cavallari, Marco ^c   Miranda, Maria Clara Sá ^a   Arosa, Fernando A ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

CD1d; Gaucher cell model; Inflammation; INKT cells; MHC class II

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CERAMIDE; CHITOTRIOSIDASE; CONDURITOL B EPOXIDE; GLYCOSIDASE INHIBITOR; IMIGLUCERASE; ISOGLOBOTRIHEXOSYLCERAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RETINOIC ACID; SPHINGOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; GAUCHER DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID STORAGE; LYMPHOCYTE FUNCTION; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MONOCYTE; NATURAL KILLER T CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD1D; ANTINEOPLASTIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINE; CHRONIC DISEASE; COCULTURE TECHNIQUES; ENZYME INHIBITORS; GAUCHER DISEASE; GLOBOSIDES; HEXOSAMINIDASES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFLAMMATION; INOSITOL; MONOCYTES; NATURAL KILLER T-CELLS; PROTEIN MULTIMERIZATION; RNA, MESSENGER; TRETINOIN; TRIHEXOSYLCERAMIDES; UP-REGULATION;

EID: 77952541606     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.07.002     Document Type: Article

References (45)

1. Amaral O., Lacerda L., Marcão A., Pinto E., Tamagnini G., Sá Miranda M.C. Homozygosity for two mild glucocerebrosidase mutations of probable Iberian origin. Clin. Genet. 1999, 56:100-102.
2. Amaral O., Lacerda L., Santos R., Pinto R.A., Aerts H., Sa Miranda MC. Type 1 Gaucher disease: molecular, biochemical, and clinical characterization of patients from northern Portugal. Biochem. Med. Metab. Biol. 1993, 49:97-107.
3. Amaral O., Marcão A., Sá Miranda M., Desnick R.J., Grace M.E. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients. Eur. J. Hum. Genet. 2000, 8:95-102.
4. Amaral O., Pinto E., Fortuna M., Lacerda L., Sá Miranda M.C. Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese. Hum. Mutat. 1996, 8:280-281.
5. Balreira A., Lacerda L., Miranda C.S., Arosa F.A. Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br. J. Haematol. 2005, 129:667-676.
6. Balreira A., Macedo M.F., Girão C., Rodrigues L.G., Oliveira J.P., Sá Miranda M.C., Arosa F.A. Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients. Br. J. Haematol. 2008, 143:601-604.
7. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., Brenner M.B. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994, 372:691-694.
8. Berges C., Naujokat C., Tinapp S., Wieczorek H., Höh A., Sadeghi M., Opelz G., Daniel V. A cell line model for the differentiation of human dendritic cells. Biochem. Biophys. Res. Commun. 2005, 333:896-907.
9. Beutler E., Grabowski G.A. Gaucher disease. The Metabolic & Molecular Bases of Inherited Disease 2001, vol. III:3635-3668. McGraw-Hill, New York.
10. + Vα24/Vβ11 invariant NKT cells in intrahepatic malignant tumors. J. Immunol. 2009, 182:5140-5151.
11. Cabrita M., Pereira C.F., Rodrigues P., Cardoso E.M., Arosa F.A. Altered expression of CD1d molecules and lipid accumulation in the human hepatoma cell line HepG2 after iron loading. FEBS J. 2005, 272:152-165.
12. Castaneda J.A., Lim M.J., Cooper J.D., Pearce D.A. Immune system irregularities in lysosomal storage disorders. Acta Neuropathol. 2008, 115:159-174.
13. Chen Q., Ross A.C. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp. Cell. Res. 2004, 297:68-81.
14. Chen Q., Ross A.C. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells. Exp. Biol. Med. 2007, 232:488-494.
15. Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M.J., Godfrey D.I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 2003, 171:4020-4027.
16. - subset. J. Exp. Med. 1993, 177:1763-1771.
17. - T cells. J. Exp. Med. 1994, 180:1171-1176.
18. Di Rosa M., Musumeci M., Scuto A., Musumeci S., Malaguarnera L. Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages. Clin. Chem. Lab. Med. 2005, 43:499-502.
19. Franchini L., Matto P., Ronchetti F., Panza L., Barbieri L., Costantino V., Mangoni A., Cavallari M., Mori L., De Libero G. Synthesis and evaluation of human T cell stimulating activity of an α-sulfatide analogue. Bioorg. Med. Chem. 2007, 15:5529-5536.
20. Gerlini G., Hefti H.P., Kleinhans M., Nickoloff B.J., Burg G., Nestle F.O. Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J. Invest. Dermatol. 2001, 117:576-582.
21. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol. Today 2000, 21:573-583.
22. Hein L.K., Meikle P.J., Hopwood J.J., Fuller M. Secondary sphingolipid accumulation in a macrophage model of Gaucher disease. Mol. Genet. Metab. 2007, 92:336-345.
23. Hollak C.E., van Weely S., van Oers M.H., Aerts J.M. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 1994, 93:1288-1292.
24. Jmoudiak M., Futerman A.H. Gaucher disease: pathological mechanisms and modern management. Br. J. Haematol. 2005, 129:178-188.
25. Kang S.J., Cresswell P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 2002, 277:44838-44844.
26. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
27. Korkotian E., Schwarz A., Pelled D., Schwarzmann G., Segal M., Futerman A.H. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 1999, 274:21673-21678.
28. Kyrklund T. Two procedures to remove polar contaminants from a crude brain lipid extract by using prepacked reversed-phase columns. Lipids 1987, 22:274-277.
29. Lacerda L., Arosa F.A., Lacerda R., Cabeda J., Porto G., Amaral O., Fortuna A., Pinto R., Oliveira P., McLaren C.E., Sá Miranda C., de Sousa M. T cell numbers relate to bone involvement in Gaucher disease. Blood Cells Mol. Dis. 1999, 25:130-138.
30. Larsson K., Lindstedt M., Borrebaeck C.A. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006, 117:156-166.
31. Leslie D.S., Dascher C.C., Cembrola K., Townes M.A., Hava D.L., Hugendubler L.C., Mueller E., Fox L., Roura-Mir C., Moody D.B., Vincent M.S., Gumperz J.E., Illarionov P.A., Besra G.S., Reynolds C.G., Brenner M.B. Serum lipids regulate dendritic cell CD1 expression and function. Immunology 2008, 125:289-301.
32. Malaguarnera L., Di Rosa M., Zambito A.M., dell'Ombra N., Nicoletti F., Malaguarnera M. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 2006, 55:1313-1320.
33. Mehta A. Epidemiology and natural history of Gaucher's disease. Eur. J. Intern. Med. 2006, 17(Suppl.):S2-S5.
34. Melián A., Geng Y.J., Sukhova G.K., Libby P., Porcelli S.A. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am. J. Pathol. 1999, 155:775-786.
35. Moody D.B., Reinhold B.B., Guy M.R., Beckman E.M., Frederique D.E., Furlong S.T., Ye S., Reinhold V.N., Sieling P.A., Modlin R.L., Besra G.S., Porcelli S.A. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997, 278:283-286.
36. Pinto R., Caseiro C., Lemos M., Lopes L., Fontes A., Ribeiro H., Pinto E., Silva E., Rocha S., Marcão A., Ribeiro I., Lacerda L., Ribeiro G., Amaral O., Sá Miranda M.C. Prevalence of lysosomal storage diseases in Portugal. Eur. J. Hum. Genet. 2004, 12:87-92.
37. - α/β T cells demonstrates preferential use of several V β genes and an invariant TCR α chain. J. Exp. Med. 1993, 178:1-16.
38. Porcelli S.A., Modlin R.L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999, 17:297-329.
39. Sa Miranda M.C., Aerts J.M., Pinto R., Fontes A., de Lacerda L.W., van Weely S., Barranger J., Tager J.M. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients. Clin. Genet. 1990, 38:218-227.
40. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., Bloom B.R., Brenner M.B., Kronenberg M., Brennan P.J., et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230.
41. Stent G., Irving L., Lewin S., Crowe S.M. The kinetics of surface expression of CD11/CD18 integrins and CD54 on monocytes and macrophages. Clin. Exp. Immunol. 1995, 100:366-376.
42. Szatmari I., Pap A., Rühl R., Ma J.X., Illarionov P.A., Besra G.S., Rajnavolgyi E., Dezso B., Nagy L. PPARγ controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 2006, 203:2351-2362.
43. Vance D.E., Sweeley C.C. Quantitative determination of the neutral glycosyl ceramides in human blood. J. Lipid Res. 1967, 8:621-630.
44. Wilson M.T., Johansson C., Olivares-Villagómez D., Singh A.K., Stanic A.K., Wang C.R., Joyce S., Wick M.J., Van Kaer L. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 2003, 100:10913-10918.
45. Zhou D., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., Teneberg S., Wang D., Proia R.L., Levery S.B., Savage P.B., Teyton L., Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.